Skip to main content
. Author manuscript; available in PMC: 2022 Aug 1.
Published in final edited form as: Clin Immunol. 2021 Jun 16;229:108778. doi: 10.1016/j.clim.2021.108778

Figure 3A. Number of Caregivers Counseled that Treatment Would Lead to Cure by Subgroup Receiving Listed Therapies.

Figure 3A.

Depiction of patients on immunoglobulin replacement, antibiotic prophyalxis, viral prophylaxis, fungal prophylaxis, in need of frequent antibiotics for infection or continued GVHD therapy stratified by recollection of being counseled that treatment would lead to cure.